ScholarIQanswers from OpenAlex & ORCID
John R. Wingard
ResearcherPublications, citations & collaboration network
John R. Wingard is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does John R. Wingard have?
ScholarIQindexed works
John R. Wingard has 772 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does John R. Wingard have?
ScholarIQcitation count
John R. Wingard has 70,444 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of John R. Wingard?
ScholarIQh-index
John R. Wingard has an h-index of 109 in OpenAlex.
What is the i10-index of John R. Wingard?
ScholarIQi10-index
John R. Wingard has an i10-index of 410 in OpenAlex.
What is the ORCID of John R. Wingard?
ScholarIQorcid
The ORCID for John R. Wingard is on the source record.
What is the OpenAlex record for John R. Wingard?
ScholarIQopenalex
The OpenAlex for John R. Wingard is on the source record.
What are the most-cited papers on John R. Wingard?
ScholarIQmost cited works
Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation
John R. Wingard, Shelly L. Carter, Thomas J. Walsh, Joanne Kurtzberg, Trudy N. Small, Lindsey R. Baden, Iris D. Gersten, Adam Mendizabal, Helen Leather, Dennis L. Confer, Richard T. Maziarz, Edward A. Stadtmauer, Javier Bolaños‐Meade, J. Martin Brown, John F. DiPersio, Michael Boeckh, Kieren A. Marr
Clinical Significance of Nephrotoxicity in Patients Treated with Amphotericin B for Suspected or Proven Aspergillosis
John R. Wingard, Paul Kubilis, Lily Lee, Gary C. Yee, Mary H. White, Walshe Louise, Raleigh A. Bowden, Elias Anaissie, John Hiemenz, John Lister
Recommended Screening and Preventive Practices for Long-Term Survivors after Hematopoietic Cell Transplantation
Navneet S. Majhail, J. Douglas Rizzo, Stephanie J. Lee, Mahmoud Aljurf, Yoshiko Atsuta, Carmem Bonfim, Linda J. Burns, Naeem Chaudhri, Stella M. Davies, Shinichiro Okamoto, Adriana Seber, Gèrard Socié, Jeff Szer, Maria Teresa Van Lint, John R. Wingard, André Tichelli
Secondary solid cancer screening following hematopoietic cell transplantation
Yoshihiro Inamoto, Nirali N. Shah, Bipin N. Savani, Bronwen E. Shaw, Allistair Abraham, Ibrahim Ahmed, Görgün Akpek, Yoshiko Atsuta, K. Scott Baker, Grzegorz Basak, Menachem Bitan, Zachariah DeFilipp, Tara Gregory, Hildegard Greinix, Mehdi Hamadani, Betty K. Hamilton, Robert J. Hayashi, David A. Jacobsohn, Rammurti T. Kamble, Kimberly A. Kasow, Nandita Khera, Hillard M. Lazarus, Adriana K. Malone, Maria Teresa Lupo Stanghellini, Steven Margossian, Lori Muffly, Maxim Norkin, Muthalagu Ramanathan, Nina Salooja, Hélène Schoemans, John R. Wingard, Baldeep Wirk, William A. Wood, Agnes S. M. Yong, C. Duncan, Mary E.D. Flowers, Navneet S. Majhail
Personalizing Busulfan-Based Conditioning: Considerations from the American Society for Blood and Marrow Transplantation Practice Guidelines Committee
Jeanne Palmer, Jeannine S. McCune, Miguel‐Angel Perales, David I. Marks, Joseph Bubalo, Mohamad Mohty, John R. Wingard, Angélo Paci, Moustapha Hassan, Christopher Bredeson, Joseph Pidala, Nina Shah, Paul Shaughnessy, Navneet S. Majhail, Jeff Schriber, Bipin N. Savani, Paul A. Carpenter